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Abstract/Summary: 
Background:Immune-monitoring using recall antigens in the delayed type hypersensitivity (DTH) 
skin test served as a valuable tool in humans. With the DTH (Multitest,Mérieux) it was possible to 
evaluate the extent of immune-modulation under clinical/field conditions but the test was phased out 
in 2002. We have characterized now an analogous test to monitor these changes by incubating whole 
blood with bacterial, fungal and viral antigens (in-vitro DTH). 
Goal:i) Characterization of the role of the main immune reactive cell types contributing to the cellular 
immune response in the in-vitro DTH and ii) Validation of the in-vitro DTH under different clinical 
and field conditions. 
Methods:As positive control whole blood was incubated in the in-vitro DTH, supernatants were 
gathered after 12, 24 and 48h. Readout parameters of this test are cytokines in the assay´s supernatant. 
To determine the role of T-cells, monocytes and natural killer (NK), these cell populations were 
depleted using magnetic beads prior to in-vitro-DTH incubation. Validation of the test has occurred 
under clinical (HIV-patients, ICU) and field-conditions (parabolic/space-flights, confinement). 
Results:T-cell depletion abandoned almost any IL-2 production and reduced IFN-γ production 
irrespective of the type of antigen, whereas CD56 depleted cultures tended to lower IL-2 secretion and 
IFN-γ and to parallel a IL-10-increase after viral challenge. This IL-10-increase was seen also in 
CD14-depleted setups. DTH read-out was significantly different under acute stress (parabolic flight) 
or chronic stress (ISS), respectively. Preliminary data of HIV infected patients demonstrate that this 
test can display the contemporary immune status during an antiviral therapy. 
Conclusion:The in-vitro DTH mirrors adaptive and innate immune activation and may serve as tool 
also for longitudinal follow up of Th1/Th2 weighed immune response under adverse life conditions on 
earth and in space. It is planned to implement the assay in the on the ISS (MoCISS). 
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